Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : International Isotopes (INIS) -- Ignore unavailable to you. Want to Upgrade?

To: hal jordan who wrote (52)	4/14/1998 11:00:00 AM
From: Richard Belanger	Read Replies (1) \| Respond to of 81

Hal - The medical community in the U.S. has been clamoring for years that there is not enough domestic production capability for medical isotopes, especially those used in radiopharmaceuticals (the vast majority of which are imported). From what I gather, the growing need for radiopharmaceuticals, coupled with the availability of the SSC LINAC, was the driving force behind INIS formation. I do not know if there are any foreign firms that directly compete in the prostate seed business. I believe, however, that most I-125 which is used in seeds is imported, as opposed to Pd-103, which is produced domestically in cyclotrons. INIS plans on producing and selling both I-125 and Pd-103 in the second half of this year. Rich